News Releases

ASOP Global Statement on FDA/DEA Online Opioid Efforts

WASHINGTON – September 30, 2019 – In response to the joint warning letters sent by the U.S. Food and Drug Administration and the U.S. Drug Enforcement Administration to online networks selling opioids, the Alliance for Safe Online Pharmacies (ASOP Global), issued the following statement:

“We applaud the FDA and DEA on the first of its kind, joint effort to curb access to illegal and deadly opioids online. Illegal online pharmacies, offering opioids like tramadol, contribute to the opioid epidemic and consumers could, unknowingly, receive substandard or counterfeit versions.

The joint warning letters sent to four online networks operating 10 websites are a model for interagency cooperation. This latest collaboration builds on an ongoing commitment to combatting the crisis, as demonstrated by Online Opioid Summits in June 2018 and April 2019 convened by the FDA with the participation of the DEA. We look forward to supporting these agencies in their continued leadership for our shared mission to protect patients online.”



The Alliance for Safe Online Pharmacies (ASOP Global), a 501(c)(4) non-profit organization headquartered in Washington, D.C. with activities in U.S., Canada, Europe, Latin America and Asia, is dedicated to protecting consumers around the world, ensuring safe access to medications, and combating illegal online drug sellers.